About: High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) wüsseschaftlicher Artikel, wo im Johr 2000 veröffentlicht worden isch (gsw) наукова стаття, опублікована в січні 2000 (uk) im Januar 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 2000 (ast) articolo scientifico (pubblicato il 2000) (it) artikull shkencor i botuar më 01 janar 2000 (sq) scientific article published on 01 January 2000 (en)
publication date	wds:Q73399801-7B779DFF-3B52-4D6F-81BC-185AD7ECB5BC
publication date	2000-01-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q73399801-117F9DC2-0807-4B79-B033-38DD6975EE20
exact match	https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702091
cites work	wds:Q73399801-1675987E-15DF-4E3A-9316-FFEC65869436 wds:Q73399801-3052E1E8-B3CD-4004-9EA0-165FAE8E3316 wds:Q73399801-3FF92EEB-AD9B-4328-8C08-A3C7C6C143A2 wds:Q73399801-4B3E8CEF-AD0D-48EF-8C31-12BCC9D54680 wds:Q73399801-8AA99FE6-E578-489E-A28B-F7562EF3ED81 wds:Q73399801-99EDAC24-B9F2-45B2-9262-52DD5DF650D3 wds:Q73399801-BEDA55CF-BA3E-484C-BCD3-F88B88A83063 wds:Q73399801-CBADCEFC-C111-4FDC-916F-7913BCFB1BBA wds:Q73399801-FB7FAEB5-DE13-4F13-9EB4-9D30F1BC9A18
cites work	Asymptotically Efficient Rank Invariant Test Procedures Graft versus leukemia effect after transplantation with interleukin-2-activated bone marrow. Correlation with eradication of residual disease Nonparametric Estimation from Incomplete Observations Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy: a reference Treatment of breast cancer Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlates Interaction of various cytokines with interleukin 2 in the generation of killer cells from human bone marrow: application in purging of leukemia
author name string	wds:Q73399801-4C3EAD7F-2A71-4096-BD99-C7351ED40F1E wds:Q73399801-70F0E27E-0A57-44D7-8576-45BCA2464AAB wds:Q73399801-8F13FB2D-F6B8-41E3-ADC9-30C4BECFE47D wds:Q73399801-C5237E00-20E8-4573-82C7-26508CE307E8 wds:Q73399801-C990505B-F5D5-4CC6-873E-B2243598330F wds:Q73399801-D787F02D-18C9-4ACE-B044-6AD3C046D00F wds:Q73399801-F9E7CDA9-AF96-4B42-B6E9-1AC32F2DF8E9
author name string	McAfee SL Colby C Sackstein R Spitzer TR Multani P Cox BF Toh HC
rdfs:label	High-dose cyclophosphamide + carboplatin and interleukin-2 (nl) High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study (en) High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study (sq)
skos:prefLabel	High-dose cyclophosphamide + carboplatin and interleukin-2 (nl) High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study (en) High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study (sq)
name	High-dose cyclophosphamide + carboplatin and interleukin-2 (nl) High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study (en) High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study (sq)
author	wds:Q73399801-16F92F30-6AEF-4B5D-8463-840A22A2C2AA
author	Rocío García-Carbonero
title	wds:Q73399801-FB975A38-41AA-41C3-84F1-B329146F7C39
title	High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study (en)
page(s)	wds:Q73399801-1BAAD961-C70A-44E0-B3FB-3B9D34008EA8
page(s)	19-24
instance of	wds:Q73399801-08D7ED09-42B8-46C4-ABE5-40524699C778
instance of	scholarly article
main subject	wds:Q73399801-1D12D6DE-8E17-44B2-AEFF-6A29B5914EF2 wds:Q73399801-9F8D4FD3-5549-409F-9CBA-629942815C5A
main subject	carboplatin breast carcinoma
PubMed ID	wds:Q73399801-D564BC22-71A4-4C10-BAF0-418596D2FA47
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10654009
PubMed ID	10654009
published in	wds:Q73399801-53591A43-2697-4060-8538-D32252037970
published in	Bone Marrow Transplantation
issue	wds:Q73399801-D25D1426-455E-47BE-B1F4-CDA25D559F6A
volume	wds:Q73399801-C71DF4A8-9BB2-4ADE-857B-ED38B238545B
issue	1
volume	25
DOI	wds:Q73399801-864D6584-225A-4FE0-A2CB-6A3C816A023C
DOI	http://dx.doi.org/10.1038/SJ.BMT.1702091
DOI	10.1038/SJ.BMT.1702091
Dimensions Publication ID	wds:Q73399801-4817F0CB-091B-402A-8C0E-B0129CFBE813
Dimensions Publication ID	1009298518
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73399801
is cites work of	Administration of low-dose interleukin-2 plus G-CSF/EPO early after autologous PBSC transplantation: effects on immune recovery and NK activity in a prospective study in women with breast and ovarian cancer The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial. Prognostic analysis of pre-transplant peripheral T-cell levels in patients receiving an autologous hematopoietic progenitor-cell transplant. Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer High-dose carboplatin and regimen-related toxicity following autologous bone marrow transplant In vitro generation of cytotoxic effectors activated by interleukin 2 (IL-2): comparison of autologous peripheral blood stem cells (PBSC) from adults and children
is cites work of	wds:Q40371959-D37282D4-166C-4551-AF28-24246BBFDE6D wds:Q51990914-9D6317BD-01AA-4D8C-9F11-CA627DECF64A wds:Q78449558-75FC8860-838E-4198-8A6E-F94C7A4F8A1A wds:Q53925120-46DE3D21-0F3F-4578-8FDE-8D50739D3F71 wds:Q94329676-3B384B6B-7B08-4D59-B893-57260C8DE8B6 wds:Q61911225-EAB81F16-179E-4D1A-9C11-E7B49769D260 wds:Q77961954-EC33572C-F5A6-4595-844B-D6D47A58544B

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software